Vappu Rantalaiho

New biomarker evidence of oxidative DNA damage in patients with non‐insulin‐dependent diabetes mellitus

Janne Leinonen, Terho Lehtimäki, Shinya Toyokuni et al. · FEBS Letters · 1997 · 262 citations · Full text

Life Sciences, Biochemistry, Endocrinology +15

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s Disease. An Open, Randomized, Multicenter Study

Dan Nordström, Ann Knight, Reijo Luukkainen et al. · The Journal of Rheumatology · 2012 · 163 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

Vappu Rantalaiho, Markku Korpela, Leena Laasonen et al. · Arthritis Research & Therapy · 2010 · 108 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes.

A P Harmoinen, Timo Kouri, Ole Wirta et al. · PubMed · 1999 · 87 citations

Medicine, Endocrinology, Nephrology +17

The good initial response to therapy with a combination of traditional disease‐modifying antirheumatic drugs is sustained over time: The eleven‐year results of the Finnish rheumatoid arthritis combination therapy trial

Vappu Rantalaiho, Markku Korpela, Pekka Hannonen et al. · Arthritis & Rheumatism · 2009 · 86 citations

Medicine, Internal Medicine, Pharmacotherapy +11